Sentinel Lymph Node Biopsy in Early Stages of Oral Squamous Cell Carcinoma Using the Receptor-Targeted Radiotracer
neck dissection
oral squamous cell carcinoma
radiotracer
sentinel lymph node biopsy
tilmanocept
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
08 Jul 2021
08 Jul 2021
Historique:
received:
06
06
2021
revised:
27
06
2021
accepted:
02
07
2021
entrez:
7
8
2021
pubmed:
8
8
2021
medline:
8
8
2021
Statut:
epublish
Résumé
Neck management in patients with early-stage, clinically node-negative oral squamous cell carcinoma (OSCC) remains a matter of discussion. Sentinel lymph node biopsy (SLNB) represents a treatment alternative to avoid elective neck dissection (END) in this cohort and different protocols and tracers exist. Here we present the clinical outcome of SLNB using
Identifiants
pubmed: 34359314
pii: diagnostics11071231
doi: 10.3390/diagnostics11071231
pmc: PMC8303850
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Oral Maxillofac Surg. 2014 Nov;43(11):1307-12
pubmed: 25128262
Head Neck. 2016 Apr;38(4):628-34
pubmed: 25524256
Ann Surg Oncol. 2004 Jul;11(7):690-6
pubmed: 15197011
Nucl Med Commun. 2019 Nov;40(11):1138-1147
pubmed: 31568193
J Surg Oncol. 2019 Aug;120(2):101-108
pubmed: 31095734
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Ann Surg Oncol. 2010 Sep;17(9):2459-64
pubmed: 20552410
PLoS One. 2017 Jan 20;12(1):e0170322
pubmed: 28107500
Br J Oral Maxillofac Surg. 2017 Oct;55(8):757-762
pubmed: 28864148
Eur J Cancer. 2019 Jan;107:86-92
pubmed: 30553161
Head Neck. 2009 Apr;31(4):503-12
pubmed: 19156833
JAMA Otolaryngol Head Neck Surg. 2013 Sep;139(9):895-902
pubmed: 24051744
J Clin Oncol. 2021 Jun 20;39(18):2025-2036
pubmed: 33877855
Head Neck. 2008 Nov;30(11):1488-96
pubmed: 18767178
Ann Surg Oncol. 2015 Oct;22(11):3708-15
pubmed: 25670018
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Dec;108(6):933-8
pubmed: 19846326
J Immunol. 2015 Sep 1;195(5):2019-29
pubmed: 26202986
J Nucl Med. 2011 Feb;52(2):180-7
pubmed: 21270454
Oral Oncol. 2010 Jun;46(6):414-7
pubmed: 20400366
Cancer. 2002 Jul 15;95(2):354-60
pubmed: 12124836
J Clin Oncol. 2020 Dec 1;38(34):4010-4018
pubmed: 33052754
J Clin Oncol. 2010 Mar 10;28(8):1395-400
pubmed: 20142602
J Surg Oncol. 2007 Sep 15;96(4):330-6
pubmed: 17879335
J Craniomaxillofac Surg. 2020 Aug;48(8):711-718
pubmed: 32718880
J Surg Res. 2019 Jan;233:149-153
pubmed: 30502241
Curr Pharm Des. 2020;26(31):3834-3839
pubmed: 32053068
J Nucl Med. 2006 May;47(5):755-62
pubmed: 16644744
Eur J Cancer. 2015 Dec;51(18):2777-84
pubmed: 26597442
J Surg Oncol. 2017 Dec;116(7):819-823
pubmed: 28695567
Clin Otolaryngol. 2016 Jun;41(3):228-33
pubmed: 26198548
N Engl J Med. 2015 Aug 6;373(6):521-9
pubmed: 26027881
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):851-858
pubmed: 32839855
J Nucl Med. 2005 Jul;46(7):1136-43
pubmed: 16000282
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):623-637
pubmed: 30564849
Oral Oncol. 2019 Mar;90:87-93
pubmed: 30846183